Less Ads, More Data, More Tools Register for FREE

Sydbank share buyback programme: transactions in week 32

15 Aug 2022 09:33

Sydbank share buyback programme: transactions in week 32

Company Announcement No 37/2022Peberlyk 46200 AabenraaDenmarkTel +45 74 37 37 37Fax +45 74 37 35 36Sydbank A/SCVR No DK 12626509, Aabenraasydbank.dk
15 August 2022Β 

Dear Sirs

Sydbank share buyback programme: transactions in week 32On 2 March 2022 Sydbank announced a share buyback programme of DKK 425m. The share buyback commenced on 7 March 2022 and will be completed by 30 December 2022.

The purpose of the share buyback programme is to reduce the share capital of Sydbank and the programme is executed in compliance with the provisions of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, collectively referred to as the Safe Harbour rules.

The following transactions have been made under the share buyback programme:

Β Number of sharesVWAPGross value (DKK)
Accumulated, most recent announcement1,062,000Β 241,772,830.00
08 August 202209 August 202210 August 202211 August 202212 August 202211,00011,00011,00011,00011,000222.40220.00221.94226.99224.862,446,400.002,420,000.002,441,340.002,496,890.002,473,460.00
Total over week 3255,000Β 12,278,090.00
Total accumulated during the share buyback programme1,117,000Β 254,050,920.00

All transactions were made under ISIN DK 0010311471 and effected by Danske Bank A/S on behalf of Sydbank A/S. Further information about the transactions, cf Article 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council on market abuse and the Commission delegated regulation, is available in the attachment.

Following the above transactions, Sydbank holds a total of 1,124,935 own shares, equal to 1.92% of the Bank’s share capital.Yours sincerely Karen FrΓΈsig Bjarne LarsenCEO Deputy Group Chief Executive

Attachment

SM 37 UK incl. enc

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS